1. Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
   Pablo García-Molina et al, 2022, Pharmaceutics CrossRef
2. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression
   Xi-Meng Lin et al, 2017, Gastroenterology CrossRef
3. Choline kinase inhibitors EB-3D and EB-3P interferes with lipid homeostasis in HepG2 cells
   Alberto Sola-Leyva et al, 2019, Scientific Reports CrossRef
4. Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases
   Juan Carlos Lacal et al, 2021, Pharmaceutics CrossRef
5. [99mTc]Tc-DTPA-Bis(cholineethylamine) as an Oncologic Tracer for the Detection of Choline Transporter (ChT) and Choline Kinase (ChK) Expression in Cancer
   Ambika Parmar Jaswal et al, 2022, ACS Omega CrossRef
6. Choline kinase inhibition and docking studies of a series of 6-(benzylthio)-9H-purin-9-yl-pyridinium derivatives
   Belén Rubio-Ruiz et al, 2017, Medicinal Chemistry Research CrossRef